Henry Ford Health System
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Henry Ford Health System sits in the top decile of US sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count).
Henry Ford Health System: 234 sponsored US clinical trials, 43 recruiting.
Henry Ford Health System sponsors 234 registered US clinical trials on ClinicalTrials.gov, 43 of them currently recruiting, and 148 completed. 35 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Insomnia, with 5 trials.
Top-decile sponsor footprint
Henry Ford Health System ranks in the top decile of sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
148 of 173 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
234 total, page 5 of 5
Safety and Accuracy of Regadenoson-Atropine Stress Echocardiography in CAD
NCT00894179
Utility of the History and Physical Exam in the Emergency Department
NCT01154517
Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
NCT00978822
Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery
NCT00796887
Use of Non Invasive Hemodynamic Cardiovascular Monitoring to Evaluate Emergency Department Patients
NCT00851214
Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia
NCT01125150
Vitiligo Skin Transplantation
NCT00830713
A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
NCT00819637
A Randomized Trial of Clinical Decision Making in Asymptomatic Carotid Stenosis
NCT01315288
Multi-arm Intervention Diabetes Adherence Study
NCT00754741
Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
NCT00720980
Magnetoencephalographic (MEG) Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia
NCT00688025
Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation
NCT00645801
Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder
NCT00688142
Treatment of Surgical Scars With Fractional Photothemolysis Versus Pulse Dye Laser
NCT00685243
Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population
NCT00799695
Randomized Trial of Suicide Gene Therapy and Prostate Cancer
NCT00583492
Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)
NCT01142947
Innovative Strategies Which Improve the Clinical Handoff (I-SWITCH)
NCT00917072
Safety and Efficacy of 1550nm Fractional Laser Treatment for Acne Scars in Fitzpatrick Type IV-VI Skin
NCT00641420
Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women
NCT00941473
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
NCT00494351
Impact of Long Wavelength Ultraviolet (UVA) and Visible Light on Melanocompetent Skin
NCT00478751
Using Information Technology to Improve Asthma Adherence
NCT00459368
Novel Technique for Botulinum Toxin Injection to Minimize Patient Discomfort
NCT00628472
Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma
NCT00415454
Tailored Asthma Management for Urban Teens
NCT00201058
Pregabalin for Abdominal Pain From Adhesions
NCT00310765
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
NCT00367224
Safety and Efficacy of Chronic Hypnotic Use
NCT01006525
Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke
NCT00452582
Changes in Physician Performance Through Continuous Professional Development
NCT00115284
Randomized Trial of Iontophoresis Versus Injection of Corticosteroids for Lateral Epicondylitis
NCT00257634
Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia
NCT00294502
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 15 |
| Phase 2 | 23 |
| Phase 3 | 9 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the Henry Ford Health System pipeline
43 recruiting of 234 indexed (18% open); 148 completed (63%).
Phase mix: 35 late (III/IV) vs 38 early (I/II) (balanced across stages).
Top condition: Insomnia (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Henry Ford Health System: open-pipeline peers nationwide
Peers matched on 234 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Henry Ford Health System sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 234 trials (± recruiting share)
- Daiichi Sankyo · 236 trials · 12% recruiting
- Loma Linda University · 237 trials · 15% recruiting
- Brown University · 231 trials · 15% recruiting
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- New York Institute of Technology · 18% recruiting · 49 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of California, San Diego · 18% recruiting · 775 trials
Related
What to do with this Henry Ford Health System page
234 registered trials is a research-attention snapshot, not an endorsement of Henry Ford Health System or any single study.
- 43 of Henry Ford Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Insomnia is the condition Henry Ford Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Insomnia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Henry Ford Health System pipeline card: 234 registered trials from official public datasets.Report a data error.